| E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of … S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ... Journal of Clinical Oncology 35 (5), 490, 2017 | 467 | 2017 |
| Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia YB Chen, S Li, AA Lane, C Connolly, C Del Rio, B Valles, M Curtis, ... Biology of Blood and Marrow Transplantation 20 (12), 2042-2048, 2014 | 257 | 2014 |
| Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation C Cutler, S Li, VT Ho, J Koreth, E Alyea, RJ Soiffer, JH Antin Blood 109 (7), 3108-3114, 2007 | 236 | 2007 |
| High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update RE George, S Li, C Medeiros-Nancarrow, D Neuberg, K Marcus, ... Journal of clinical oncology 24 (18), 2891-2896, 2006 | 235 | 2006 |
| Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity Z DeFilipp, JU Peled, S Li, J Mahabamunuge, Z Dagher, AE Slingerland, ... Blood advances 2 (7), 745-753, 2018 | 211 | 2018 |
| Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3‐ITD acute myeloid leukaemia in first complete remission AM Brunner, S Li, AT Fathi, M Wadleigh, VT Ho, K Collier, C Connolly, ... British journal of haematology 175 (3), 496-504, 2016 | 197 | 2016 |
| Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation C Cutler, NL Henry, C Magee, S Li, HT Kim, E Alyea, V Ho, SJ Lee, ... Biology of Blood and Marrow Transplantation 11 (7), 551-557, 2005 | 190 | 2005 |
| Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity A Lacasce, O Howard, S Li, D Fisher, A Weng, D Neuberg, M Shipp Leukemia & lymphoma 45 (4), 761-767, 2004 | 169 | 2004 |
| THE MOLECULAR ANALYSIS FOR THERAPY CHOICE (NCI-MATCH) TRIAL: LESSONS for GENOMIC TRIAL DESIGN KT Flaherty, R Gray, A Chen, S Li, D Patton, SR Hamilton, PM Williams, ... JNCI: Journal of the National Cancer Institute, 2020 | 165 | 2020 |
| Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate-and non-methotrexate-containing graft-versus-host disease prophylaxis regimens C Cutler, S Li, HT Kim, P Laglenne, KC Szeto, L Hoffmeister, MJ Harrison, ... Biology of Blood and Marrow Transplantation 11 (5), 383-388, 2005 | 161 | 2005 |
| Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays RE George, EF Attiyeh, S Li, LA Moreau, D Neuberg, C Li, EA Fox, ... PLoS One 2 (2), 2007 | 139 | 2007 |
| Nivolumab is effective in mismatch repair–deficient noncolorectal cancers: Results from arm Z1D—A subprotocol of the NCI-MATCH (EAY131) study NS Azad, RJ Gray, MJ Overman, JD Schoenfeld, EP Mitchell, JA Zwiebel, ... Journal of Clinical Oncology 38 (3), 214-222, 2020 | 136 | 2020 |
| Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia JR Brown, HT Kim, S Li, K Stephans, DC Fisher, C Cutler, V Ho, SJ Lee, ... Biology of Blood and Marrow Transplantation 12 (10), 1056-1064, 2006 | 127 | 2006 |
| Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI … KL Jhaveri, XV Wang, V Makker, SW Luoh, EP Mitchell, JA Zwiebel, ... Annals of Oncology 30 (11), 1821-1830, 2019 | 120 | 2019 |
| Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials A Argiris, S Li, M Ghebremichael, AM Egloff, L Wang, AA Forastiere, ... Annals of oncology 25 (7), 1410-1416, 2014 | 118 | 2014 |
| Phase 2 trial of epothilone B analog BMS‐247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800) A trial of the eastern cooperative oncology group R Dreicer, S Li, J Manola, NB Haas, BJ Roth, G Wilding Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 93 | 2007 |
| Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer A Argiris, S Li, P Savvides, JP Ohr, J Gilbert, MA Levine, A Chakravarti, ... Journal of Clinical Oncology 37 (34), 3266-3274, 2019 | 89 | 2019 |
| Phase 2 trial of high‐dose rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation … YB Chen, T Batchelor, S Li, E Hochberg, M Brezina, S Jones, C Del Rio, ... Cancer 121 (2), 226-233, 2015 | 74 | 2015 |
| E1308: Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction … A Cmelak, S Li, S Marur, W Zhao, WH Westra, CH Chung, ML Gillison, ... Journal of Clinical Oncology 32 (15_suppl), LBA6006-LBA6006, 2014 | 74 | 2014 |
| Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic … PS Martin, S Li, S Nikiforow, EP Alyea, JH Antin, P Armand, CS Cutler, ... Haematologica 101 (4), 499-505, 2016 | 65 | 2016 |
